Impact factors (IFs) are published each year by Clarivate Analytics, a provider of multiple products pertaining to scientific research insights. Impact factors reflect a journal’s performance and status through a record of how often its articles are cited in other biomedical journals. The release of IF data is eagerly awaited each year by publishers and editorial teams. The data released last month ranked journals with respect to citations during 2025 of articles published during 2023-2024.
The IF for Pharmacotherapy increased from 3.4 to 4.0, placing the journal in the top one-third of all journals in the Pharmacy and Pharmacology category. The IF for the Journal of the American College of Clinical Pharmacy (JACCP) increased from 1.5 to 1.7, and the journal continues to grow in submissions and reach.
The IF should not be the sole measure of journal quality, but it remains a vital measure in biomedical publishing of a journal’s impact on its field. The journal’s citation metrics alongside data on downloads, international readership, and comparisons with other journals are all measures of its success.
ACCP journal publication is made possible through the combined efforts of many individuals, including publication staff, editors, editorial board members, and reviewers. Most important are the authors who choose to submit their best work to the official journals of ACCP, Pharmacotherapy and JACCP.
Included among the top articles published in 2023-2024 with the most citations in 2025 are the following.
